IBM's Quantum Gambit: Racing Toward 2029 While Wall Street Waits for a Comeback
Published on 09/02/2026 at 03:02 | Editorial boerse-global.de
The arithmetic hanging over IBM's stock is unforgiving. Down 23 percent since January, trading roughly 32 percent below its June peak of 292.85 euros, the technology giant is asking investors to look past a bruised present and bet on a future built from silicon spin qubits, dual-architecture processors, and a deepening alliance with OpenAI.
That future took a decisive step forward in late August when IBM closed its acquisition of HRL Laboratories, the research outfit previously co-owned by Boeing and General Motors. The deal, announced on August 26, brings in-house expertise in silicon-spin qubits and advanced quantum sensing — capabilities that extend beyond IBM's existing superconducting-qubit approach and feed directly into the company's roadmap for a fault-tolerant quantum computer by 2029. Financial terms were not disclosed.
The HRL purchase capped a dense stretch of technical activity. On August 19, IBM announced it had coupled two cryogenic modules into a single cooled environment for the first time — a prerequisite for scaling the kind of fault-tolerant quantum processors the company hopes to commercialize within the decade. Together, the two developments signal that IBM is broadening its quantum toolkit rather than doubling down on a single technology path.
A Mainframe Reboot and a $240 Million Cloud Bet
Quantum, however, is not the only front where IBM is placing chips. At the Hot-Chips conference on August 24, the company unveiled its first dual-architecture mainframe processor, designed to power future IBM Z and LinuxONE systems with native support for both IBM and Arm computing platforms. The move is an attempt to modernize the mainframe franchise — the very business at the center of a legal review that continues to shadow the stock.
The law firm Bleichmar Fonti & Auld is still examining whether IBM misrepresented the strength of its IBM Z outlook before the share price dropped 25 percent on July 14. That investigation has been public for weeks, but it remains a persistent drag on investor confidence even as management pushes forward with new growth initiatives.
Should investors sell immediately? Or is it worth buying IBM?
On the AI infrastructure side, IBM signed a multi-year agreement worth $240 million with Together AI to build a large-scale inference cluster in the IBM Cloud, based on Nvidia HGX B300 systems and slated to become available in the first quarter of 2027. The deal complements the OpenAI partnership announced in mid-August, under which IBM Consulting will help enterprises scale AI applications using GPT-5.6 frontier models — a joint sales arrangement that embeds OpenAI technology directly into IBM's consulting platform.
Insider Moves Paint a Mixed Picture
Disclosures from the executive suite offer conflicting signals. CEO Arvind Krishna acquired 8,375.56 phantom stock units on August 27 at a reference price of $238.79 through the company's Excess Savings Plan, lifting his holdings to 28,447.47 units. The day before, Senior Vice President Robert Thomas sold 25,000 IBM shares at a weighted average price of $230.32 — proceeds of roughly $5.76 million — leaving him with 47,800.35 direct shares. Thomas had reduced his stake by 34 percent during the final week of August, a move that typically draws scrutiny even if insider transactions alone rarely dictate investment decisions.
Dividend Discipline and a Bruised Chart
Amid the strategic repositioning, IBM has kept its shareholder promise intact. In early August, the board approved a regular quarterly dividend of $1.69 per share for shareholders of record as of August 10, maintaining a payout policy that has become a cornerstone of the stock's appeal during the current downturn.
That downturn has been unforgiving. At the German trading venue, IBM shares closed Tuesday at 198.92 euros, down 1.2 percent on the day. The stock sits 12 percent below its 200-day average — a technical signal that the medium-term downtrend remains firmly in place — and 5.7 percent under its 50-day average of 211.94 euros. The gap to the 52-week high of 292.85 euros, reached in early June, underscores how much ground has been lost since the summer's guidance cut and disappointing quarterly results.
Visibility Beyond the Balance Sheet
IBM is also seeking consumer-facing exposure. As digital transformation partner of the US Open from August 23 to September 13, the company is deploying AI-powered features including a new "Serve Quality" metric and an expanded "Match Chat" assistant built on watsonx. The sponsorship with the United States Tennis Association may do little for the financials, but it keeps the IBM brand attached to marquee events while the company's core turnaround plays out.
The next test arrives October 21, when IBM reports earnings. By then, investors will want to see whether the OpenAI partnership, the HRL acquisition, and the Together AI contract are translating into measurable momentum — or whether the stock's slide has further to run before the quantum payoff arrives.
Ad
IBM Stock: New Analysis - 2 September
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
